Telo Historical Financial Ratios
| TELO Stock | CAD 0.12 0.01 9.09% |
Telo Genomics is promptly reporting on over 82 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 0.13, Invested Capital of 0.0, Average Payables of 479.8 K or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Telo Genomics Corp financial condition quickly.
Telo |
About Telo Financial Ratios Analysis
Telo Genomics CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Telo Genomics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Telo financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Telo Genomics history.
Telo Genomics Financial Ratios Chart
Add Fundamental
Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Telo Genomics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Telo Genomics Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telo Genomics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. At this time, Telo Genomics' Graham Number is fairly stable compared to the past year. Shareholders Equity Per Share is likely to climb to 0.13 in 2024, despite the fact that Free Cash Flow Yield is likely to grow to (0.12).
Telo Genomics fundamentals Correlations
Click cells to compare fundamentals
Telo Genomics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Telo Genomics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Ptb Ratio | (1.58) | 9.27 | 6.36 | 8.06 | 6.79 | 22.38 | |
| Book Value Per Share | (0.079) | 0.0259 | 0.0786 | 0.0444 | 0.0434 | 0.008266 | |
| Free Cash Flow Yield | (0.2) | (0.16) | (0.0475) | (0.0868) | (0.15) | (0.19) | |
| Operating Cash Flow Per Share | (0.0248) | (0.0374) | (0.0236) | (0.0306) | (0.0437) | (0.0344) | |
| Pb Ratio | (1.58) | 9.27 | 6.36 | 8.06 | 6.79 | 22.38 | |
| Free Cash Flow Per Share | (0.0248) | (0.0377) | (0.0238) | (0.031) | (0.0449) | (0.0345) | |
| Roic | 1.28 | (1.64) | (0.34) | (0.8) | (1.06) | (4.62) | |
| Net Income Per Share | (0.0812) | (0.0415) | (0.0228) | (0.036) | (0.0469) | (0.038) | |
| Cash Per Share | 0.001474 | 0.0308 | 0.0776 | 0.0459 | 0.0444 | 0.0112 | |
| Pocfratio | (5.04) | (6.42) | (21.23) | (11.68) | (6.75) | (5.37) | |
| Pfcf Ratio | (5.04) | (6.37) | (21.05) | (11.52) | (6.58) | (5.36) | |
| Days Payables Outstanding | 1.9K | 3.5K | 1.8K | 1.7K | 2.0K | 2.5K | |
| Income Quality | 0.31 | 0.9 | 1.03 | 0.85 | 0.93 | 0.91 | |
| Roe | 1.03 | (1.6) | (0.29) | (0.81) | (1.08) | (4.6) | |
| Ev To Operating Cash Flow | (5.84) | (5.63) | (17.97) | (10.21) | (5.74) | (5.05) | |
| Pe Ratio | (1.54) | (5.78) | (21.91) | (9.94) | (6.29) | (4.87) | |
| Return On Tangible Assets | (4.09) | (1.08) | (0.28) | (0.75) | (0.97) | (2.86) | |
| Ev To Free Cash Flow | (5.84) | (5.59) | (17.82) | (10.06) | (5.6) | (5.04) | |
| Earnings Yield | (0.1) | (0.65) | (0.17) | (0.0456) | (0.16) | (0.21) | |
| Net Debt To E B I T D A | (0.27) | 0.77 | 3.57 | 1.3 | 0.95 | 0.3 | |
| Current Ratio | 0.0634 | 2.94 | 33.09 | 14.66 | 10.14 | 2.45 | |
| Tangible Book Value Per Share | (0.079) | 0.0254 | 0.0783 | 0.0441 | 0.0432 | 0.008037 | |
| Graham Number | 0.0964 | 0.38 | 0.16 | 0.2 | 0.19 | 0.0841 | |
| Shareholders Equity Per Share | (0.079) | 0.0259 | 0.0786 | 0.0444 | 0.0434 | 0.008266 | |
| Graham Net Net | (0.0953) | 0.0189 | 0.0758 | 0.0425 | 0.04 | 0.006218 | |
| Enterprise Value Over E B I T D A | (1.97) | (5.48) | (19.7) | (8.94) | (5.43) | (4.65) | |
| Price Earnings Ratio | (1.54) | (5.78) | (21.91) | (9.94) | (6.29) | (4.87) | |
| Price Book Value Ratio | (1.58) | 9.27 | 6.36 | 8.06 | 6.79 | 22.38 | |
| Price Earnings To Growth Ratio | (0.45) | 0.12 | 0.49 | (0.17) | (0.21) | 0.26 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.